TET2 gene mutation status associated with poor prognosis of transition zone prostate cancer: a retrospective cohort study based on whole exome sequencing and machine learning models.

Front Endocrinol (Lausanne) · 2025 · PMC12034557 · PMID 40297177

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

did not reach statistical significancep=0.051so close (0.05 < p ≤ 0.1)

A similar trend toward advanced pathological T stage (≥T2) was observed in TET2 mutant patients, though this difference approached but did not reach statistical significance (14.7% vs. 30.4%, p=0.051).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.